📰 Early Access Program News
Page 35 - Early Access Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Early Access Program. Real-time updates on events, politics, business and more.
April 21, 2022
Hansa Biopharma AB (publ) (OTC:HNSBF) Q1 2022 Earnings Conference Call April 21, 2022 8:00 AM ET Company Participants Søren Tulstrup – Chief Executive Officer Conference Call Participants...
April 21, 2022
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
April 18, 2022
Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) and PDF Solutions, Inc. (NASDAQ: PDFS) today announced their existing relationship is expanding to...
April 14, 2022
As of December 31, 2021, cash and cash equivalents were €43.3 million and turnover was €1.0 million Success of Euronext Paris IPO in November 2021 with €35.7 million capital raised, after
April 13, 2022
ZURICH, SWITZERLAND / ACCESSWIRE / April 13, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery
April 13, 2022
DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the launch of a new program for customers of their SYNTAX System, in which organizations receive early access to the latest advancements of their EDS technology. Dubbed the DNA Scriptors Early Access Program, its members already include the London Biofoundry and the BASE facility at the University of Queensland (UQ), Australia.
April 12, 2022
Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin. DNA Script, a world leader in
April 7, 2022
Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival
April 7, 2022
LYON, France--(BUSINESS WIRE)--$MAAT--Regulatory News:MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival outcomes for patients with cancer, announced today the initiation of a Phase 2a...
April 4, 2022
/PRNewswire/ -- NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, was invited to present a poster at...